PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 -0.01 (-1.63%)
As of: Oct 1, 2026 · 3:59 PM EDT

PharmaCyte Biotech (PMCB) Change in Receivables (2010 - 2012)

Updated

PharmaCyte Biotech's Change in Receivables was -$2,581 in FY2013 (year ended Apr 30, 2013), compared with $6,762 in FY2012.

Analysis

PharmaCyte Biotech (PMCB) Change in Receivables (2010 - 2012) Analysis & Trends

  • Per Business Quant data, Change in Receivables in earlier fiscal years was $6,762 in FY2012 and -$931.00 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 PharmaCyte Biotech 4.40 Mn 4.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2012 -2,581.00
Apr 30, 2012 -10,501.00
Jan 31, 2012 10,617.00
Oct 31, 2011 12,937.00
Jul 31, 2011 -6,291.00
Apr 30, 2011 18,976.00
Jan 31, 2011 -17,317.00
Oct 31, 2010 -8,677.00
Jul 31, 2010 6,087.00
API Access

PharmaCyte Biotech Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=PMCB&period=max&api_key=YOUR_API_KEY